Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Enterobiasis Age: Adults |
Dose: Tablet – 100 mg Frequency: single dose Note: If cure is not achieved 3 weeks after treatment, a second course of treatment is advised. |
|
Indication: Enterobiasis Age: Adults |
Dose: Suspension – 5 ml (1 teaspoonful) Frequency: single dose Note: If cure is not achieved 3 weeks after treatment, a second course of treatment is advised. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Enterobiasis Age: greater than 2 |
Dose: Tablet – 100 mg Frequency: single dose Note: If cure is not achieved 3 weeks after treatment, a second course of treatment is advised |
|
Indication: Enterobiasis Age: greater than 2 |
Dose: Suspension – 5 ml (1 teaspoonful) Frequency: single dose Note: If cure is not achieved 3 weeks after treatment, a second course of treatment is advised |
Administration
- Can take with/without food
- Can be chewed/crushed
Side Effect
- Transient diarrhoea
- abdominal pain
- nausea
- vomiting
- headache
- tinnitus
- numbness
- fever
- alopecia
- rash
- pruritus
- urticaria
- angioedema
- flushing
- hiccups
- cough
- weakness
- drowsiness
- chills
- hypotension
- seizures
- transient abnormalities in LFT (eg increased serum concentrations of aminotransferases, glutamyltransferase alkaline phosphatase and/or bilirubin)
- hepatitis
- increased BUN
- decreased Hb concentration and/or hematocrit
- leucopenia
- eosinophilia
- haematuria
- cylindruria
- migration of roundworms through the mouth and nose
- Myelosuppression
- manifested as neutropenia (including agranulocytosis) and/or thrombocytopenia
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Carbamazepine, Phenytoin
|
Decreased plasma concentrations
|
|
Cimetidine
|
Increased plasma concentrations
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool (Below 25°C temperature) and dry place, protected from light. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.